About Index Trending news
Analyze
Pricing
Bay City Capital

Bay City Capital

Work at Bay City Capital? Add yourself to this profile

Bay City Capital

Edit Profile
More info

Elsewhere

Also headquartered in San Francisco

Twitter Twitter Uber Uber Instagram Instagram Airbnb Airbnb Lyft Lyft Reddit Reddit Salesforce Salesforce Fitbit Fitbit TechCrunch TechCrunch Slack Slack

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 24

Portfolio
Add info
Robert Gould

Robert Gould

Health and Wellness +1
Total funding
$43.5M in 3 rounds from 7 investors
By Bay City Capital
$32M Series B in Oct, 2009
Hyperion Therapeutics, Inc

Hyperion Therapeutics, Inc

Health Care +1
Total funding
$115M in 3 rounds from 10 investors
By Bay City Capital
$60M Series C in Jun, 2009
Exit Horizon Pharma plc, Mar 30, 2015
Tria Beauty

Tria Beauty

E-Commerce
Total funding
$169.3M in 8 rounds from 23 investors
By Bay City Capital
$45.5M Private equity in Jul, 2013
Nabsys, Inc.

Nabsys, Inc.

Biotechnology
Total funding
$81.5M in 5 rounds from 9 investors
By Bay City Capital
$35M Series D in Mar, 2013
Epocrates

Epocrates

Mobile +3
Total funding
$35M in 2 rounds from 10 investors
By Bay City Capital
undisclosed deal in Aug, 2002
Exit Athenahealth, Jan 7, 2013
Nevro

Nevro

Biotechnology +2
Total funding
$231M in 3 rounds from 17 investors
By Bay City Capital
$48M Series C in Mar, 2013
Dermira, Inc.

Dermira, Inc.

Biotechnology
Total funding
$129.5M in 4 rounds from 16 investors
By Bay City Capital
$51M Series C in Aug, 2014
Omicia

Omicia

Big Data +3
Total funding
$29.8M in 2 rounds from 12 investors
By Bay City Capital
$6.8M Series A in Jan, 2014
Exit Spiral Genetics, Jan 23, 2017
Aviir

Aviir

Testing +2
Total funding
$49.4M in 11 rounds from 26 investors
By Bay City Capital
$10M Series B in Dec, 2011
IDEV Technologies

IDEV Technologies

Biotechnology
Total funding
$46M in 1 rounds from 5 investors
By Bay City Capital
$46M Series D in Oct, 2010
Exit Abbott, Jul 15, 2013
Interleukin Genetics

Interleukin Genetics

Health and Wellness +1
Total funding
$20.6M in 3 rounds from 3 investors
By Bay City Capital
$12M Post-IPO equity in May, 2013
Iterum Therapeutics

Iterum Therapeutics

Therapeutics
Total funding
$105M in 2 rounds from 13 investors
By Bay City Capital
$65M Series B in May, 2017
Vtesse, Inc.

Vtesse, Inc.

Biotechnology
Total funding
$42M in 2 rounds from 6 investors
By Bay City Capital
$17M Series A in Jul, 2016

Want to see the complete list?
Go Pro!